Enabling next-generation drug delivery technology

InteRNA’s drug delivery technology for miRNAs is based on 3rd generation lipid nanoparticles (LNP), incl.  tissue-specific lipid linkers for improved distribution and uptake thereby addressing key criteria as distribution to cell of interest, cellular uptake, endosomal escape and prevention of on-target toxicity and off-target effects.